Leonardo Tariciotti, M.D. (@leonard_t_md) 's Twitter Profile
Leonardo Tariciotti, M.D.

@leonard_t_md

Fellow in Neurological Surgery (Emory University 🇺🇸). PGY5 (University of Milan 🇮🇹). #Neurooncology | #Skullbase | #Brainmapping | #AI

ID: 487948580

linkhttps://www.linkedin.com/feed/ calendar_today09-02-2012 22:33:59

169 Tweet

295 Followers

600 Following

Brain (@brain1878) 's Twitter Profile Photo

Herbet et al. examine how machine learning algorithms can be used during presurgical planning to predict cognitive outcomes following glioma resection. tinyurl.com/y6pvdt94

Herbet et al. examine how machine learning algorithms can be used during presurgical planning to predict cognitive outcomes following glioma resection. tinyurl.com/y6pvdt94
Leonardo Tariciotti, M.D. (@leonard_t_md) 's Twitter Profile Photo

The 2024 annual meeting of the Subcortical Surgery Group (SSG) just ended and a lot of notes and new concepts to pack and bring back. #ENRICH results and next steps. New ideas on oncological uses of #MIPS were ignited. #SSG #SSG2024 Subcortical Surgery Group

The 2024 annual meeting of the Subcortical Surgery Group (SSG) just ended and a lot of notes and new concepts to pack and bring back. 
#ENRICH results and next steps. 
New ideas on oncological uses of #MIPS were ignited. #SSG #SSG2024 <a href="/subcorticalsurg/">Subcortical Surgery Group</a>
Philipp Karschnia (@pkarschnia) 's Twitter Profile Photo

RANO review on the oncological role of surgery in diffuse gliomas published in The Lancet Oncology - and excitingly featured on the cover page ⭐️ open access: shorturl.at/zTdJD ❓ evidence that surgery matters for glioma patients in the era of the WHO 2021 classification 🧵

RANO review on the oncological role of surgery in diffuse gliomas published in <a href="/TheLancetOncol/">The Lancet Oncology</a> - and excitingly featured on the cover page ⭐️ 

open access: shorturl.at/zTdJD

❓ evidence that surgery matters for glioma patients in the era of the WHO 2021 classification 🧵
Andrew Ng (@andrewyng) 's Twitter Profile Photo

Announcing new open-source Python package: aisuite! This makes it easy for developers to use large language models from multiple providers. When building applications I found it a hassle to integrate with multiple providers. Aisuite lets you pick a "provider:model" just by

Announcing new open-source Python package: aisuite!  

This makes it easy for developers to use large language models from multiple providers. When building applications I found it a hassle to integrate with multiple providers. Aisuite lets you pick a "provider:model" just by
Journal of Neuro-Oncology (@jneurooncol) 's Twitter Profile Photo

Krenzlin et al demonstrated that glioblastomas with multiple lesions treated with multimodal therapy equal survival rates compared to patients with solitary lesion tumors. #JNO Read more: ow.ly/vuE050Uh288

Krenzlin et al demonstrated that glioblastomas with multiple lesions treated with multimodal therapy equal survival rates compared to patients with solitary lesion tumors. #JNO

Read more: ow.ly/vuE050Uh288
Paul McCoubrie (@pmccoubrie) 's Twitter Profile Photo

Are you using noise reduction software on your CT KUBs? Beware! We had a near miss recently Very modern software (this one is a deep-learning algorithm) can smooth out even 7mm calculi Check your scanner as AI isn’t always that smart

Are you using noise reduction software on your CT KUBs?

Beware! We had a near miss recently

Very modern software (this one is a deep-learning algorithm) can smooth out even 7mm calculi 

Check your scanner as AI isn’t always that smart
Norbert Galldiks (@galldiks) 's Twitter Profile Photo

Happy to share our latest work: academic.oup.com/noa/advance-ar… Our initial results suggest the potential of amino acid PET using FET for identifying metabolic responders to vorasidenib in IDH-mutant gliomas #EANO #PETImaging #AminoAcidPET #vorasidenib #FETPET Uniklinik Köln Forschungszentrum Jülich | @[email protected]

Neurosurgery Publications (@neurosurgerycns) 's Twitter Profile Photo

#ONSNew Biportal Endoscopic TransOrbital and transMaxillary Approach to the Cranio-Orbital Region and Middle Cranial Fossa: A Preliminary Analysis of Maneuverability bit.ly/4aIb2CY by Leonardo Tariciotti, M.D. et al Emory School of Medicine Olabisi Sanusi MD, FAANS CNS

#ONSNew Biportal Endoscopic TransOrbital and transMaxillary Approach to the Cranio-Orbital Region and Middle Cranial Fossa: A Preliminary Analysis of Maneuverability bit.ly/4aIb2CY by <a href="/Leonard_T_MD/">Leonardo Tariciotti, M.D.</a> et al <a href="/EmoryMedicine/">Emory School of Medicine</a> <a href="/MdOlabisi/">Olabisi Sanusi MD, FAANS</a> <a href="/CNS_Update/">CNS</a>
Gustavo (@gusviani) 's Twitter Profile Photo

Meningioma Grading Will Never Be the Same: 🔑 Takeaways from cIMPACT-NOW Update 8 OncoAlert For oncologists & radiation oncologists: here’s what you need to know about the molecular era of meningiomas🧵(1/14)

Meningioma Grading Will Never Be the Same: 🔑 Takeaways from cIMPACT-NOW Update 8 <a href="/OncoAlert/">OncoAlert</a> 
For oncologists &amp; radiation oncologists: here’s what you need to know about the molecular era of meningiomas🧵(1/14)
Emory Neurosurgery (@emoryneurosurg) 's Twitter Profile Photo

We have enrolled our 1st patient into the REACH clinical trial led by Gustavo Pradilla Dr. Gustavo Pradilla. This is the 1st study to investigate the use of minimally invasive parafascicular surgery for deep ICH, particularly within anterior basal ganglia. #neurosurgery #REACH

We have enrolled our 1st patient into the REACH clinical trial led by <a href="/gpradil2/">Gustavo Pradilla</a> Dr. Gustavo Pradilla. This is the 1st study to investigate the use of minimally invasive parafascicular surgery  for deep ICH, particularly within anterior basal ganglia. #neurosurgery #REACH